Literature DB >> 12581438

Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso.

Sodiomon Bienvenu Sirima1, Amadou Konaté, Alfred B Tiono, Nathalie Convelbo, Simon Cousens, Franco Pagnoni.   

Abstract

In rural, malaria-endemic Burkina Faso, we evaluated the impact of the use of pre-packaged antimalarial drugs (PPAM), by mothers in the home, on the progression of disease in children from uncomplicated fever to severe malaria. In each village of one province, a core group of opinion leaders (mainly older mothers) was trained in the management of uncomplicated malaria, including the administration of PPAM. Full courses of antimalarial (chloroquine) and antipyretic (aspirin) drugs were packaged in age-specific bags and made widely available through community health workers who were supplied through the existing drug distribution system. Drugs were sold under a cost-recovery scheme. Local schoolteachers conducted surveys in a random sample of 32 villages at the end of the high transmission seasons in 1998 and 1999. Disease history and the treatment received were investigated for all children under the age of 6 years having suffered from a fever episode in the previous 4 weeks. 'Uncomplicated malaria' was defined as every episode of fever and 'severe malaria' as every episode of fever followed by convulsions or loss of consciousness. During the study period, 56%[95% confidence interval (CI) 50-62%] of 3202 fever episodes in children under 6 years of age were treated promptly by mothers with the pre-packaged drugs made available by the study. A total of 59% of children receiving PPAM were reported to have received the drugs over the prescribed 3-day period, while 52% received the correct age-specific dose. PPAM use was similar among literate (61%) and non-literate mothers (55%) (P = 0.08). The overall reported risk of developing severe malaria was 8%. This risk was lower in children treated with PPAM (5%) than in children not treated with PPAM (11%) (risk ratio = 0.47; 95% CI 0.37, 0.60; P < 0.0001). This estimate of the impact of PPAM was largely unchanged when account was taken of potential confounding by age, sex, maternal literacy status, year or village. Our findings support the view that, after appropriate training and with adequately packaged drugs made available, mothers can recognize and treat promptly and correctly malarial episodes in their children and, by doing so, reduce the incidence of severe disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12581438     DOI: 10.1046/j.1365-3156.2003.00997.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  76 in total

1.  The role of community participation in intermittent preventive treatment of childhood malaria in southeastern Ghana.

Authors:  S K Kpormegbe; C K Ahorlu
Journal:  Ghana Med J       Date:  2014-06

2.  Why do policies change? Institutions, interests, ideas and networks in three cases of policy reform.

Authors:  Jessica C Shearer; Julia Abelson; Bocar Kouyaté; John N Lavis; Gill Walt
Journal:  Health Policy Plan       Date:  2016-05-27       Impact factor: 3.344

Review 3.  Unit-dose packaged drugs for treating malaria.

Authors:  L Orton; G Barnish
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

4.  Parents' perceptions, attitudes and acceptability of treatment of childhood malaria with artemisinin combination therapies in ghana.

Authors:  G O Adjei; A K Darkwah; B Q Goka; C Bart-Plange; M L Alifrangis; J A L Kurtzhals; O P Rodrigues
Journal:  Ghana Med J       Date:  2009-09

5.  Community acceptability of use of rapid diagnostic tests for malaria by community health workers in Uganda.

Authors:  David Mukanga; James K Tibenderana; Juliet Kiguli; George W Pariyo; Peter Waiswa; Francis Bajunirwe; Brian Mutamba; Helen Counihan; Godfrey Ojiambo; Karin Kallander
Journal:  Malar J       Date:  2010-07-13       Impact factor: 2.979

6.  Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study.

Authors:  Billy E Ngasala; Maja Malmberg; Anja M Carlsson; Pedro E Ferreira; Max G Petzold; Daniel Blessborn; Yngve Bergqvist; José P Gil; Zul Premji; Andreas Mårtensson
Journal:  Malar J       Date:  2011-03-16       Impact factor: 2.979

7.  Feasibility and acceptability of home-based management of malaria strategy adapted to Sudan's conditions using artemisinin-based combination therapy and rapid diagnostic test.

Authors:  Khalid A Elmardi; Elfatih M Malik; Tarig Abdelgadir; Salah H Ali; Abdalla H Elsyed; Mahmoud A Mudather; Asma H Elhassan; Ishag Adam
Journal:  Malar J       Date:  2009-03-09       Impact factor: 2.979

8.  Use of drugs, perceived drug efficacy and preferred providers for febrile children: implications for home management of fever.

Authors:  Elizeus Rutebemberwa; Xavier Nsabagasani; George Pariyo; Goran Tomson; Stefan Peterson; Karin Kallander
Journal:  Malar J       Date:  2009-06-12       Impact factor: 2.979

9.  Access to malaria treatment in young children of rural Burkina Faso.

Authors:  Maike Tipke; Valérie R Louis; Maurice Yé; Manuela De Allegri; Claudia Beiersmann; Ali Sié; Olaf Mueller; Albrecht Jahn
Journal:  Malar J       Date:  2009-11-24       Impact factor: 2.979

10.  Options for the delivery of intermittent preventive treatment for malaria to children: a community randomised trial.

Authors:  Margaret Kweku; Jayne Webster; Martin Adjuik; Samuel Abudey; Brian Greenwood; Daniel Chandramohan
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.